Advanced search
Publication Cover
Breast Cancer: Targets and Therapy Volume 10, 2018 - Issue
Submit an article Journal homepage
93
Views
4
CrossRef citations to date
0
Altmetric
Original Research

A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts

Yayun Liang1 Deparment of Biomedical Sciences and Dalton Cardiovascular Research Center, Columbia, MO, USA
,
Benford Mafuvadze1 Deparment of Biomedical Sciences and Dalton Cardiovascular Research Center, Columbia, MO, USA
,
Cynthia Besch-Williford2 IDEXX BioResearch, Columbia, MO, USA
&
Salman M Hyder1 Deparment of Biomedical Sciences and Dalton Cardiovascular Research Center, Columbia, MO, USACorrespondence[email protected]
Pages 53-67 | Published online: 22 Mar 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.